Abstract
Osmium tetroxide 2,2’-bipyridine (OsBp) is known to react with pyrimidines in ssDNA and preferentially label deoxythymine (T) over deoxycytosine (C). The product, osmylated DNA, was proposed as a surrogate for nanopore-based DNA sequencing due to OsBp’s “perfect” label attributes. Osmylated deoxyoligos translocate unassisted and measurably slow via sub-2 nm SiN solid-state nanopores, as well as via the alpha-hemolysin (α-HL) pore. Both nanopores discriminate clearly between osmylated and intact nucleobase; α-HL was also shown to discriminate between osmylated T and osmylated C. Experiments presented here confirm that the kinetics of osmylation are comparable for short oligos and long ssDNA and show that pyrimidine osmylation is practically complete in two hours at room temperature with less than 15 mM OsBp. Under the proposed labeling conditions: deoxyoligo backbone degradation measures less than 1/1,000,000; false positives such as osmylated deoxyadenine (A) and osmylated deoxyguanine (G) measure less than 1/100,000; false negatives, i.e., unosmylated C measure less than 1/10,000; and unosmylated T must measure substantially lower than 1/10,000 due to the 27-fold higher reactivity of T compared to C. However, osmylated C undergoes degradation that amounts to about 1–2% for the duration of the labeling protocol. This degradation may be further characterized, possibly suppressed, and the properties of the degradation products via nanopore translocation can be evaluated to assure base calling quality in a DNA sequencing effort.
Highlights
At the time the human genome was completed in 2001 [1,2], it was becoming clear that the relationships between genes, noncoding regions, epigenetic modifications, and the transcriptome were intertwined and led to health vs disease in complex patterns
Earlier studies identified a chromophore, resulting from the formation of the pyrimidine/OsBp bond, which absorbs in the range of 300 to 320 nm where DNA has practically no absorbance [30,31,32]
These studies selected two wavelengths and their absorbance ratio (R = A(λ = 312 nm)/A(λ = 272 nm), i.e., the absorbance at 312 nm divided by the absorbance at 272 nm) as optimal for monitoring the osmylation of either T or T + C
Summary
At the time the human genome was completed in 2001 [1,2], it was becoming clear that the relationships between genes, noncoding regions, epigenetic modifications, and the transcriptome were intertwined and led to health vs disease in complex patterns. For the more typical cases where the oligo/DNA has 5 or more pyrimidines, the resolution between intact and osmylated nucleic acid is lost, and the substrate/product appears as a single broad peak.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.